Cinacalcet
Cinacalcet Hydrochloride
12 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Cinacalcet Hydrochloride
Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | generic | 12 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 9 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 9 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 6 | SUPPLYING |
| XLCare Pharmaceuticals Inc. | unknown | 6 | SUPPLYING |
| Accord Healthcare Inc. | generic | 6 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 3 | SUPPLYING |
| Strides Pharma Science Limited | generic | 3 | SUPPLYING |
| AvPAK | repackager | 1 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Dissolution Specifications. — Recalling firm: Strides Pharma, Inc. — Product was distributed nationwide within the United States
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: ACCORD HEALTHCARE, INC. — Nationwide in the USA and PR
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: ACCORD HEALTHCARE, INC. — Nationwide in the USA and PR
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: ACCORD HEALTHCARE, INC. — Nationwide in the USA and PR
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA